INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 116 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,000 | -60.0% | 486 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | 0.0% | 486 | -21.9% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 622 | -26.0% | 0.00% | – |
| Q1 2018 | $5,000 | -16.7% | 840 | +32.1% | 0.00% | – |
| Q4 2017 | $6,000 | -33.3% | 636 | -32.5% | 0.00% | -100.0% |
| Q3 2017 | $9,000 | -30.8% | 942 | -9.8% | 0.00% | 0.0% |
| Q2 2017 | $13,000 | -45.8% | 1,044 | -59.8% | 0.00% | -66.7% |
| Q4 2016 | $24,000 | -52.0% | 2,600 | -38.1% | 0.00% | -40.0% |
| Q3 2016 | $50,000 | -16.7% | 4,200 | +100.0% | 0.01% | -44.4% |
| Q4 2015 | $60,000 | +62.2% | 2,100 | +61.5% | 0.01% | +80.0% |
| Q3 2015 | $37,000 | -50.7% | 1,300 | -38.1% | 0.01% | -50.0% |
| Q2 2015 | $75,000 | +59.6% | 2,100 | +162.5% | 0.01% | +42.9% |
| Q1 2015 | $47,000 | -67.1% | 800 | -76.5% | 0.01% | -66.7% |
| Q4 2014 | $143,000 | +8.3% | 3,400 | 0.0% | 0.02% | +10.5% |
| Q3 2014 | $132,000 | -15.4% | 3,400 | -32.0% | 0.02% | -9.5% |
| Q2 2014 | $156,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 6,171,440 | $54,802,000 | 0.52% |
| Regal Investment Advisors LLC | 161,600 | $1,435,000 | 0.34% |
| Folger Hill Asset Management LP | 396,315 | $3,519,000 | 0.30% |
| SCHNEIDER CAPITAL MANAGEMENT CORP | 181,900 | $1,615,000 | 0.29% |
| Mirae Asset Global Investments Co., Ltd. | 1,033,683 | $9,179,000 | 0.17% |
| JW Asset Management, LLC | 29,409 | $72,000 | 0.05% |
| TCI Wealth Advisors, Inc. | 9,516 | $85,000 | 0.04% |
| GAM Holding AG | 83,940 | $745,000 | 0.03% |
| Freedom Investment Management, Inc. | 63,032 | $560,000 | 0.03% |
| Sterling Investment Advisors, Ltd. | 5,000 | $44,000 | 0.03% |